ZURICH/BERLIN, Nov 17 (Reuters) - Here are some of the main
factors that may affect Swiss stocks on Wednesday:
ROCHE ROG.S
Roche has ended a partnership with Atea Pharmaceuticals Inc
AVIR.O to jointly develop a COVID-19 antiviral pill, the Swiss
drugmaker said on Tuesday, a month after the drug failed to help
patients in a small study. urn:newsml:reuters.com:*:nL4N2S748C
COMPANY STATEMENTS
* Credit Suisse CSGN.S said it had appointed Benjamin
Cavalli the head of wealth management in Asia Pacific. CSGN.S
* Montana Aerospace AG AERO.S : launches accelerated
bookbuilding for private placement of new registered shares
worth up to around CHF 150 million AERO.S
* Aryzta AG ARYN.S : achieved 9.8% organic growth in Q1 for
continuing operations comprising of 8% volume growth and a 1.8%
price/mix improvement; reiterates FY 2022 guidance for
mid-single digit organic revenue growth with positive volume and
pricing contributions ARYN.S
ANALYSTS' VIEWS
SONOVA HOLDING AG SOON.S : CREDIT SUISSE RAISES TARGET
PRICE TO CHF 415 FROM CHF 400
ECONOMY
No major Swiss economic data scheduled
(Reporting by Zurich newsroom and Berlin Speed Desk)
((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
((For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German .SDE
All SMI constituent stocks 0#.SSMI
DJ STOXX index .STOXX
Top 10 STOXX sectors .PGL.STOXXS
Top 10 EUROSTOXX sectors .PGL.STOXXES
Swiss mid-cap index .SSMI
Swiss all-share index .SSHI
Swiss market digest .AD.S
Sector overview CH/SECTOR1
All Swiss news CH
Swiss research news CH-RCH
All equity news E
SPEED GUIDES: EQUITY EQUITY/NEWS1 EUR/EQUITY SWITZERLAND REUTERS ))